CD20 COUNT / EDTA BLOOD

image not found

NABL Cap Accredited 

The CD20 Count test measures CD20-positive B lymphocytes in EDTA blood, aiding in the evaluation of B-cell disorders and immune function. It is particularly useful in diagnosing and monitoring conditions such as lymphomas and in assessing response to B-cell–targeted therapies. Metropolis Healthcare uses advanced flow cytometry to ensure precise and dependable CD20 count results. These results support clinicians in accurate diagnosis and effective treatment monitoring.

  • 17 Crores+ Samples Processed
  • World Class Technology Labs
  • 25+ Years of Trust & Experience
  • Free Home Collection

Price: Rs. 3,050.00

Sample Type: EDTA BLOOD

Fasting Not Required


Notes: C0064

Frequently Asked Questions (FAQ's):

What does this test include?
This test measures CD20-positive B-cell counts in EDTA blood, performed with accuracy by Metropolis Healthcare.

How does Metropolis Healthcare perform this test?
Metropolis Healthcare uses flow cytometry to detect and quantify CD20 expression on B lymphocytes.

Who should take this test?
Patients with suspected lymphoma, B-cell disorders, or those on targeted therapy can benefit at Metropolis Healthcare.

Why is CD20 testing important?
Metropolis Healthcare uses this test to assess B-cell involvement and monitor therapy effectiveness.

Do I need to fast before this test?
No fasting is required; Metropolis Healthcare only needs an EDTA blood sample.

What do low CD20 counts indicate?
Low counts at Metropolis Healthcare may reflect B-cell depletion or effective targeted therapy.

What do high CD20 counts mean?
High levels at Metropolis Healthcare can occur in proliferative or reactive B-cell conditions.

How long does it take to get results?
Metropolis Healthcare ensures timely and accurate results to support clinical decision-making.

 
 

OUR corporates PARTNER

Feedback

Patient's Testimonials

Trusted by Thousands

OUR Accreditations

OUR Lab